Megan D. Demers

Abbott Fund

Papers

1

Total Citations

11

H-Index

1

About

Megan D. Demers is a structural biologist whose work bridges the gap between protein engineering and drug discovery, with a particular focus on kinase biology. Her most cited study, "Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study" (2009), exemplifies her expertise in using targeted protein modifications to enable crystallographic studies and accelerate the development of selective inhibitors. By demonstrating how strategic mutations can stabilize flexible protein regions without compromising functional relevance, Demers provided a methodological blueprint that has been adopted in both academic and pharmaceutical settings. Though her citation record reflects a focused body of work, her contributions to the MAPKAP kinase 2 field have been instrumental in advancing our understanding of this important therapeutic target, which is implicated in inflammatory and cancer pathways. Demers’ approach—combining rigorous biochemical characterization with practical structure-based design—highlights her ability to translate fundamental protein chemistry into actionable tools for drug development, making her a valuable contributor to the structural biology community.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study
11 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Abbott Fund

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago